ZyCov-D, India’s first COVID-19 vaccine for those above 12 years, gets DGCI nod
First Published: 21st August, 2021 16:41 IST
India’s drug regulator DGCI has approved Gujarat-based Zydus Cadila’s three-dose COVID-19 vaccine for emergency use authorisation for in adults and children aged 12 years and above, bringing in the sixth vaccine
India’s drug regulator DGCI has approved Gujarat-based Zydus Cadila’s three-dose COVID-19 vaccine for emergency use authorisation for in adults and children aged 12 years and above, bringing in the sixth vaccine authorised for use in the country.
Zydus Cadila’s vaccine, developed in partnership with the Department of Biotechnology, is the second home-grown shot to get emergency authorisation in India after Bharat Biotech’s Covaxin.
With the central drug regulator clearing the vaccine, Zydus Cadila’s ZyCoV-D is set to become the first Covid vaccine candidate developed on a plasmid DNA platform to be commercially introduced anywhere in the world.
The vaccine has been tested on 1,000 children above the age of 12 and had demonstrated a primary efficacy of 66.66 per cent in phase 3 clinical trials. It was the first Covid-19 vaccine in India to be tested in the adolescent population — those in the 12-18-year age group.
ZyCoV-D is the world’s first Covid-19 vaccine built on a DNA platform to be granted emergency use authorisation. Unlike mRNA vaccines, DNA-based vaccines do not require ultra-cold storage systems and are said to be more cost-effective.
So far, there are three vaccines that are being used in India’s immunisation drive — SII’s Covishield, Bharat Biotech’s Covaxin and Russia’s Sputnik V. Top government sources said the Zydus DNA COVID-19 vaccine is likely to arrive in the market by October.
COMMENTS
TOPMOST STORY NOW
Live Suspense continues over Rahul, Priyanka’s candidatures from Raebareli and Amethi; final decision today
02nd May 2024
Live Meghalaya petrol bomb attacks: Asked DGP to ensure such incidents do not repeat, says Dy CM Prestone Tynsong
01st May 2024
Live Petrol bombs the new weapon of violence in Meghalaya?
01st May 2024
Live PMEAC Member Sanjeev Sanyal delivers Prof Sarat Mahanta Memorial Lecture in Guwahati
01st May 2024
WE RECOMMEND
Suspense continues over Rahul, Priyanka’s candidatures from Raebareli and Amethi; final decision today
The sources added that along with Congress leaders, its partners in the INDIA bloc also suggested that Rahul contest Amethi.
02nd May 2024
Close to 100 schools in Delhi-NCR get bomb threat mails. Who sent the mails? What is the truth?
According to Delhi Police, the bomb threats sent via email to schools originated from Russia, as indicated by the IP address of the email, which was traced back to the domain "mail.ru"
01st May 2024
Multiple schools across Delhi-NCR receive bomb threat, students evacuated; Delhi Police begin probe
Bomb detection teams, bomb disposal squads and officials of Delhi Fire Service have been rushed to schools and search operations are underway, a police officer said.
01st May 2024
Delhi HC directs government to frame policy for compensating deaths due to Chinese ‘manjha’
In 2017, the Chinese Manjha was banned by the Indian government.
01st May 2024
Licence of 14 Patanjali products cancelled. Check details here
In an affidavit filed in the Supreme Court, the licencing body said that it had suspended licenses of 14 products manufactured by Patanjali's Divya Pharmacy in connection with the misleading advertisements case.
30th April 2024